

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chaperone-mediated protein transport (GO:0072321) | 4.87837494 |
| 2 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.49424553 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 4.49027578 |
| 4 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.24266946 |
| 5 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.79384331 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.75764198 |
| 7 | proteasome assembly (GO:0043248) | 3.68305509 |
| 8 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.53332260 |
| 9 | protein targeting to mitochondrion (GO:0006626) | 3.44464155 |
| 10 | GDP-mannose metabolic process (GO:0019673) | 3.41179033 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 3.35587864 |
| 12 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.33421353 |
| 13 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.33039483 |
| 14 | ATP synthesis coupled proton transport (GO:0015986) | 3.33039483 |
| 15 | deoxyribonucleotide catabolic process (GO:0009264) | 3.27833824 |
| 16 | inner mitochondrial membrane organization (GO:0007007) | 3.24632496 |
| 17 | viral transcription (GO:0019083) | 3.23668245 |
| 18 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.14618799 |
| 19 | pyrimidine-containing compound salvage (GO:0008655) | 3.14327051 |
| 20 | pyrimidine nucleoside salvage (GO:0043097) | 3.14327051 |
| 21 | deoxyribose phosphate catabolic process (GO:0046386) | 3.12850684 |
| 22 | establishment of protein localization to mitochondrion (GO:0072655) | 3.11432571 |
| 23 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.11356406 |
| 24 | protein targeting to ER (GO:0045047) | 3.10085031 |
| 25 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.08915038 |
| 26 | translational termination (GO:0006415) | 3.04917258 |
| 27 | pseudouridine synthesis (GO:0001522) | 3.04647103 |
| 28 | protein localization to endoplasmic reticulum (GO:0070972) | 3.03030427 |
| 29 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.02937505 |
| 30 | cotranslational protein targeting to membrane (GO:0006613) | 3.01983367 |
| 31 | DNA strand elongation (GO:0022616) | 3.01820438 |
| 32 | formation of translation preinitiation complex (GO:0001731) | 3.01259636 |
| 33 | mitotic chromosome condensation (GO:0007076) | 3.00996982 |
| 34 | protein localization to mitochondrion (GO:0070585) | 2.97915006 |
| 35 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.97903428 |
| 36 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.97835686 |
| 37 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.97401123 |
| 38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.93809073 |
| 39 | DNA deamination (GO:0045006) | 2.93446631 |
| 40 | nucleoside salvage (GO:0043174) | 2.92775867 |
| 41 | maturation of SSU-rRNA (GO:0030490) | 2.90425920 |
| 42 | rRNA modification (GO:0000154) | 2.90009817 |
| 43 | protein maturation by protein folding (GO:0022417) | 2.88277945 |
| 44 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.87470410 |
| 45 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.86865742 |
| 46 | respiratory electron transport chain (GO:0022904) | 2.85179353 |
| 47 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.84756168 |
| 48 | regulation of mitochondrial translation (GO:0070129) | 2.84749026 |
| 49 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.83009352 |
| 50 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.83009352 |
| 51 | nucleotide salvage (GO:0043173) | 2.82262871 |
| 52 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.82127547 |
| 53 | ribosomal large subunit biogenesis (GO:0042273) | 2.81346765 |
| 54 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.81187671 |
| 55 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.80539769 |
| 56 | translational elongation (GO:0006414) | 2.80525992 |
| 57 | cellular response to arsenic-containing substance (GO:0071243) | 2.78313359 |
| 58 | regulation of DNA methylation (GO:0044030) | 2.77865308 |
| 59 | translation (GO:0006412) | 2.76808497 |
| 60 | telomere maintenance via recombination (GO:0000722) | 2.75667538 |
| 61 | electron transport chain (GO:0022900) | 2.75602724 |
| 62 | cellular component biogenesis (GO:0044085) | 2.74076041 |
| 63 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.73657321 |
| 64 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.72473405 |
| 65 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.72003273 |
| 66 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.70849748 |
| 67 | negative regulation of ligase activity (GO:0051352) | 2.70849748 |
| 68 | viral life cycle (GO:0019058) | 2.69157446 |
| 69 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.68291003 |
| 70 | ribosome biogenesis (GO:0042254) | 2.67330222 |
| 71 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.67101062 |
| 72 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.67101062 |
| 73 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.65088166 |
| 74 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.65088166 |
| 75 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.65088166 |
| 76 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.63540647 |
| 77 | termination of RNA polymerase III transcription (GO:0006386) | 2.63540647 |
| 78 | base-excision repair, AP site formation (GO:0006285) | 2.63136312 |
| 79 | establishment of chromosome localization (GO:0051303) | 2.62684489 |
| 80 | mitotic metaphase plate congression (GO:0007080) | 2.60974403 |
| 81 | regulation of chemokine biosynthetic process (GO:0045073) | 2.60328922 |
| 82 | autophagic vacuole fusion (GO:0000046) | 2.60170358 |
| 83 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.59675953 |
| 84 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.59675953 |
| 85 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.58792340 |
| 86 | translational initiation (GO:0006413) | 2.58289216 |
| 87 | positive regulation of ligase activity (GO:0051351) | 2.57814844 |
| 88 | deoxyribonucleotide metabolic process (GO:0009262) | 2.56118329 |
| 89 | deoxyribose phosphate metabolic process (GO:0019692) | 2.52478468 |
| 90 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.50365554 |
| 91 | pentose metabolic process (GO:0019321) | 2.50238996 |
| 92 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.48560786 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.45531954 |
| 94 | purine nucleotide salvage (GO:0032261) | 2.45287735 |
| 95 | mitotic recombination (GO:0006312) | 2.44813491 |
| 96 | organelle membrane fusion (GO:0090174) | 2.44040689 |
| 97 | protein localization to chromosome, centromeric region (GO:0071459) | 2.43233648 |
| 98 | L-phenylalanine metabolic process (GO:0006558) | 2.41510072 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.41510072 |
| 100 | protein deneddylation (GO:0000338) | 2.41295571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.69809086 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.58202757 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.46066587 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.32906856 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.14876718 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.14191880 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.99194212 |
| 8 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.84946866 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72302636 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.71902217 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.71356356 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.56915784 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.47784373 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.43069176 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.42737021 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.39784137 |
| 17 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.38448911 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.20516425 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.12449083 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.12210731 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10787035 |
| 22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.00632355 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.97198924 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.95590756 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.93975961 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.93480025 |
| 27 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.91828730 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90120196 |
| 29 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.90107639 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86756345 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.84734504 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.79182309 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.77862891 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.76333795 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75124746 |
| 36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71619532 |
| 37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.67173780 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62870593 |
| 39 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.60637651 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59551324 |
| 41 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.59273614 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59160060 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58301744 |
| 44 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.57123980 |
| 45 | MYC_22102868_ChIP-Seq_BL_Human | 1.56156837 |
| 46 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.54664875 |
| 47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54517844 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53341073 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53256049 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52883901 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49479983 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48366600 |
| 53 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47865496 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46822113 |
| 55 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.44421255 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41668394 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.39580589 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38991989 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38604296 |
| 60 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.38088074 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33692526 |
| 62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32239971 |
| 63 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29365957 |
| 64 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29318744 |
| 65 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.29278235 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.29004635 |
| 67 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27642411 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.26763971 |
| 69 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26445095 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26196564 |
| 71 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22630925 |
| 72 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21027596 |
| 73 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20580496 |
| 74 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19986984 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19184972 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18923299 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17982517 |
| 78 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17423702 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16177890 |
| 80 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13885062 |
| 81 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.13804196 |
| 82 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12735120 |
| 83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10328821 |
| 84 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07040156 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06337118 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06259487 |
| 87 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02993563 |
| 88 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00298731 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98535195 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97643920 |
| 91 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96336129 |
| 92 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.96246140 |
| 93 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94436128 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93654594 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93409123 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92558138 |
| 97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92467056 |
| 98 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.91871844 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91346069 |
| 100 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.90644056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.98228015 |
| 2 | MP0005451_abnormal_body_composition | 3.53661234 |
| 3 | MP0003718_maternal_effect | 2.87295005 |
| 4 | MP0009333_abnormal_splenocyte_physiolog | 2.82674594 |
| 5 | MP0010094_abnormal_chromosome_stability | 2.79028329 |
| 6 | MP0003693_abnormal_embryo_hatching | 2.65623180 |
| 7 | MP0005671_abnormal_response_to | 2.57509141 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.53821582 |
| 9 | MP0003786_premature_aging | 2.37251052 |
| 10 | MP0003077_abnormal_cell_cycle | 2.32853601 |
| 11 | MP0005408_hypopigmentation | 2.32381932 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.28365830 |
| 13 | MP0006036_abnormal_mitochondrial_physio | 2.15425111 |
| 14 | MP0004957_abnormal_blastocyst_morpholog | 2.01781079 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.00899082 |
| 16 | MP0009785_altered_susceptibility_to | 1.93855586 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.93335433 |
| 18 | MP0003186_abnormal_redox_activity | 1.92444618 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.92201353 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.77053456 |
| 21 | MP0000372_irregular_coat_pigmentation | 1.73812019 |
| 22 | MP0001873_stomach_inflammation | 1.72590807 |
| 23 | MP0008058_abnormal_DNA_repair | 1.69488081 |
| 24 | MP0001800_abnormal_humoral_immune | 1.66695082 |
| 25 | MP0006082_CNS_inflammation | 1.64987468 |
| 26 | MP0004233_abnormal_muscle_weight | 1.61144432 |
| 27 | MP0001853_heart_inflammation | 1.58816213 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.54542645 |
| 29 | MP0002723_abnormal_immune_serum | 1.53085403 |
| 30 | MP0002398_abnormal_bone_marrow | 1.52992632 |
| 31 | MP0002132_abnormal_respiratory_system | 1.50290420 |
| 32 | MP0008995_early_reproductive_senescence | 1.50110889 |
| 33 | MP0008057_abnormal_DNA_replication | 1.49133589 |
| 34 | MP0008007_abnormal_cellular_replicative | 1.48484211 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.47491116 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.45900711 |
| 37 | MP0000685_abnormal_immune_system | 1.45247969 |
| 38 | MP0001819_abnormal_immune_cell | 1.44153071 |
| 39 | MP0009840_abnormal_foam_cell | 1.39590608 |
| 40 | MP0005360_urolithiasis | 1.35199129 |
| 41 | MP0005025_abnormal_response_to | 1.35031120 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.33585203 |
| 43 | MP0001790_abnormal_immune_system | 1.33541164 |
| 44 | MP0005387_immune_system_phenotype | 1.33541164 |
| 45 | MP0008004_abnormal_stomach_pH | 1.33538431 |
| 46 | MP0008932_abnormal_embryonic_tissue | 1.33368964 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.32235043 |
| 48 | MP0004381_abnormal_hair_follicle | 1.31442144 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.28962723 |
| 50 | MP0000358_abnormal_cell_content/ | 1.27808111 |
| 51 | MP0000716_abnormal_immune_system | 1.26795650 |
| 52 | MP0003436_decreased_susceptibility_to | 1.23854748 |
| 53 | MP0002419_abnormal_innate_immunity | 1.22664162 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.21499040 |
| 55 | MP0002429_abnormal_blood_cell | 1.21034708 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.20684327 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 1.19070298 |
| 58 | MP0008789_abnormal_olfactory_epithelium | 1.16871161 |
| 59 | MP0002722_abnormal_immune_system | 1.14821226 |
| 60 | MP0005395_other_phenotype | 1.14269101 |
| 61 | MP0001661_extended_life_span | 1.12127434 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.10989960 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.10058853 |
| 64 | MP0000858_altered_metastatic_potential | 1.09930254 |
| 65 | MP0008469_abnormal_protein_level | 1.07465439 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.07374952 |
| 67 | MP0001881_abnormal_mammary_gland | 1.06554856 |
| 68 | MP0003950_abnormal_plasma_membrane | 1.05897533 |
| 69 | MP0009697_abnormal_copulation | 1.05303637 |
| 70 | MP0000343_altered_response_to | 1.03755193 |
| 71 | MP0005501_abnormal_skin_physiology | 1.03214091 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.00714448 |
| 73 | MP0000371_diluted_coat_color | 0.98494471 |
| 74 | MP0000313_abnormal_cell_death | 0.97032247 |
| 75 | MP0005410_abnormal_fertilization | 0.96338698 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.93550350 |
| 77 | MP0001727_abnormal_embryo_implantation | 0.93260604 |
| 78 | MP0001764_abnormal_homeostasis | 0.92821614 |
| 79 | MP0002405_respiratory_system_inflammati | 0.92238013 |
| 80 | MP0000678_abnormal_parathyroid_gland | 0.91029958 |
| 81 | MP0003699_abnormal_female_reproductive | 0.89493753 |
| 82 | MP0005394_taste/olfaction_phenotype | 0.89367738 |
| 83 | MP0005499_abnormal_olfactory_system | 0.89367738 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.89329180 |
| 85 | MP0001919_abnormal_reproductive_system | 0.89135293 |
| 86 | MP0010307_abnormal_tumor_latency | 0.88384450 |
| 87 | MP0003075_altered_response_to | 0.88279718 |
| 88 | MP0001929_abnormal_gametogenesis | 0.88101091 |
| 89 | MP0001545_abnormal_hematopoietic_system | 0.87433586 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 0.87433586 |
| 91 | MP0002210_abnormal_sex_determination | 0.86943035 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.86766365 |
| 93 | MP0005266_abnormal_metabolism | 0.86538718 |
| 94 | MP0005389_reproductive_system_phenotype | 0.86512892 |
| 95 | MP0000350_abnormal_cell_proliferation | 0.82840387 |
| 96 | MP0010155_abnormal_intestine_physiology | 0.81757372 |
| 97 | MP0000490_abnormal_crypts_of | 0.78246951 |
| 98 | MP0001730_embryonic_growth_arrest | 0.78058741 |
| 99 | MP0002160_abnormal_reproductive_system | 0.77700124 |
| 100 | MP0003646_muscle_fatigue | 0.76848568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.45713054 |
| 2 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.79542712 |
| 3 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.60599585 |
| 4 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.60599585 |
| 5 | Rough bone trabeculation (HP:0100670) | 3.59997959 |
| 6 | Chromsome breakage (HP:0040012) | 3.54401287 |
| 7 | Oral leukoplakia (HP:0002745) | 3.53872404 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.41365258 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.37184170 |
| 10 | Reticulocytopenia (HP:0001896) | 3.34932314 |
| 11 | Hypokinesia (HP:0002375) | 3.09954705 |
| 12 | Mitochondrial inheritance (HP:0001427) | 3.06611201 |
| 13 | Increased IgM level (HP:0003496) | 2.96551885 |
| 14 | Acute encephalopathy (HP:0006846) | 2.94671836 |
| 15 | Renal Fanconi syndrome (HP:0001994) | 2.92358286 |
| 16 | Abnormal trabecular bone morphology (HP:0100671) | 2.85755000 |
| 17 | Reduced antithrombin III activity (HP:0001976) | 2.84603589 |
| 18 | Type I transferrin isoform profile (HP:0003642) | 2.83741203 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 2.81507387 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 2.79911354 |
| 21 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.79042489 |
| 22 | Increased CSF lactate (HP:0002490) | 2.78114903 |
| 23 | Ureteral duplication (HP:0000073) | 2.68319629 |
| 24 | Hypergonadotropic hypogonadism (HP:0000815) | 2.67583870 |
| 25 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.64869707 |
| 26 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.64700210 |
| 27 | Microretrognathia (HP:0000308) | 2.64201869 |
| 28 | Lipid accumulation in hepatocytes (HP:0006561) | 2.63696232 |
| 29 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.63624325 |
| 30 | Pancytopenia (HP:0001876) | 2.62606334 |
| 31 | Progressive macrocephaly (HP:0004481) | 2.62261095 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.60304169 |
| 33 | Abnormal protein glycosylation (HP:0012346) | 2.55240480 |
| 34 | Abnormal glycosylation (HP:0012345) | 2.55240480 |
| 35 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.55240480 |
| 36 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.55240480 |
| 37 | Increased intramyocellular lipid droplets (HP:0012240) | 2.55179434 |
| 38 | Increased hepatocellular lipid droplets (HP:0006565) | 2.55021066 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.53641634 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.52495511 |
| 41 | Granulocytopenia (HP:0001913) | 2.48053714 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.47561311 |
| 43 | Ragged-red muscle fibers (HP:0003200) | 2.46434850 |
| 44 | Eosinophilia (HP:0001880) | 2.45772931 |
| 45 | Hepatic necrosis (HP:0002605) | 2.37253917 |
| 46 | Lactic acidosis (HP:0003128) | 2.36601591 |
| 47 | Progressive muscle weakness (HP:0003323) | 2.31476697 |
| 48 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.30048176 |
| 49 | Increased serum lactate (HP:0002151) | 2.26719847 |
| 50 | Duplicated collecting system (HP:0000081) | 2.24392512 |
| 51 | Abnormality of placental membranes (HP:0011409) | 2.23539272 |
| 52 | Amniotic constriction ring (HP:0009775) | 2.23539272 |
| 53 | Hepatocellular necrosis (HP:0001404) | 2.23000184 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.22784249 |
| 55 | Nausea (HP:0002018) | 2.21864417 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21669613 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21669613 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21669613 |
| 59 | Abnormality of DNA repair (HP:0003254) | 2.21126577 |
| 60 | Self-mutilation (HP:0000742) | 2.18998308 |
| 61 | Respiratory difficulties (HP:0002880) | 2.18003722 |
| 62 | Exercise intolerance (HP:0003546) | 2.17515556 |
| 63 | Cerebral edema (HP:0002181) | 2.16114363 |
| 64 | Abnormality of the umbilical cord (HP:0010881) | 2.15602500 |
| 65 | Neutropenia (HP:0001875) | 2.14730475 |
| 66 | Abnormality of the preputium (HP:0100587) | 2.14386227 |
| 67 | Abnormality of B cell number (HP:0010975) | 2.14310607 |
| 68 | Exertional dyspnea (HP:0002875) | 2.14018146 |
| 69 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.13569837 |
| 70 | Cholecystitis (HP:0001082) | 2.12435632 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.12435632 |
| 72 | Abnormality of T cells (HP:0002843) | 2.11500654 |
| 73 | Recurrent viral infections (HP:0004429) | 2.10437426 |
| 74 | Premature ovarian failure (HP:0008209) | 2.08927310 |
| 75 | Increased serum ferritin (HP:0003281) | 2.05961656 |
| 76 | Abnormality of the renal collecting system (HP:0004742) | 2.01396009 |
| 77 | Premature graying of hair (HP:0002216) | 1.96779781 |
| 78 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.96214966 |
| 79 | Thrombocytosis (HP:0001894) | 1.95574408 |
| 80 | Multiple enchondromatosis (HP:0005701) | 1.92852911 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 1.92849358 |
| 82 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.90422241 |
| 83 | Cellular immunodeficiency (HP:0005374) | 1.90089512 |
| 84 | Respiratory failure (HP:0002878) | 1.90020948 |
| 85 | Loss of speech (HP:0002371) | 1.88211069 |
| 86 | Entropion (HP:0000621) | 1.87565787 |
| 87 | Abnormal spermatogenesis (HP:0008669) | 1.87179821 |
| 88 | Horseshoe kidney (HP:0000085) | 1.85833497 |
| 89 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85181610 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 1.84249802 |
| 91 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.83169957 |
| 92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.81980926 |
| 93 | Petechiae (HP:0000967) | 1.81666243 |
| 94 | Hypertensive crisis (HP:0100735) | 1.80082384 |
| 95 | Abnormality of the prostate (HP:0008775) | 1.80015046 |
| 96 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.79692338 |
| 97 | Absent thumb (HP:0009777) | 1.78065649 |
| 98 | Increased serum pyruvate (HP:0003542) | 1.77398109 |
| 99 | Abnormality of eosinophils (HP:0001879) | 1.76639857 |
| 100 | Paralysis (HP:0003470) | 1.76506293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.27640619 |
| 2 | BUB1 | 4.01183361 |
| 3 | TAOK3 | 3.72716915 |
| 4 | TXK | 3.66135277 |
| 5 | MAP4K1 | 2.99466462 |
| 6 | IRAK3 | 2.52672093 |
| 7 | STK16 | 2.24943666 |
| 8 | BCKDK | 2.24340884 |
| 9 | TESK2 | 2.13530553 |
| 10 | VRK2 | 2.11661684 |
| 11 | TLK1 | 1.93274002 |
| 12 | MST4 | 1.89959886 |
| 13 | ARAF | 1.89797299 |
| 14 | ZAK | 1.67471006 |
| 15 | MARK3 | 1.62961717 |
| 16 | TESK1 | 1.62917176 |
| 17 | EIF2AK3 | 1.53261630 |
| 18 | CDK19 | 1.48032913 |
| 19 | AURKA | 1.43460831 |
| 20 | KDR | 1.33465419 |
| 21 | TAOK2 | 1.29772675 |
| 22 | CDK8 | 1.29275944 |
| 23 | RIPK4 | 1.27984069 |
| 24 | BRSK1 | 1.20981410 |
| 25 | BRAF | 1.19977263 |
| 26 | PDK2 | 1.17827630 |
| 27 | PIM2 | 1.16604037 |
| 28 | IKBKB | 1.12583811 |
| 29 | NEK2 | 1.10077809 |
| 30 | MAPKAPK3 | 1.08359224 |
| 31 | TBK1 | 1.06519716 |
| 32 | MAP3K3 | 1.06474090 |
| 33 | BMPR2 | 1.05986563 |
| 34 | MAP3K13 | 1.05148369 |
| 35 | CDC7 | 0.98205139 |
| 36 | NUAK1 | 0.97751800 |
| 37 | AURKB | 0.96076472 |
| 38 | PLK1 | 0.94458356 |
| 39 | PBK | 0.93570131 |
| 40 | ZAP70 | 0.91938290 |
| 41 | CDK7 | 0.91085720 |
| 42 | NME1 | 0.90526383 |
| 43 | MAPK11 | 0.88992399 |
| 44 | BRSK2 | 0.88370846 |
| 45 | ILK | 0.87351162 |
| 46 | IRAK2 | 0.86005821 |
| 47 | CDK9 | 0.85559023 |
| 48 | TTK | 0.85066902 |
| 49 | ABL2 | 0.83957039 |
| 50 | ICK | 0.80338252 |
| 51 | MAP2K3 | 0.78404615 |
| 52 | MOS | 0.77021076 |
| 53 | ERN1 | 0.76114708 |
| 54 | CHEK2 | 0.74385960 |
| 55 | NEK1 | 0.73782337 |
| 56 | STK24 | 0.73402399 |
| 57 | PAK4 | 0.72256180 |
| 58 | CDK3 | 0.71590078 |
| 59 | SRPK1 | 0.71543544 |
| 60 | MYLK | 0.71385068 |
| 61 | WEE1 | 0.71097192 |
| 62 | MELK | 0.68986738 |
| 63 | PAK1 | 0.68878904 |
| 64 | CDK4 | 0.68417333 |
| 65 | MAP3K8 | 0.67300027 |
| 66 | VRK1 | 0.67115868 |
| 67 | TYK2 | 0.66238267 |
| 68 | ATR | 0.65447444 |
| 69 | IKBKE | 0.64430205 |
| 70 | LRRK2 | 0.63850127 |
| 71 | PRKCI | 0.63385101 |
| 72 | GRK6 | 0.63215533 |
| 73 | CSNK1G1 | 0.61343061 |
| 74 | RPS6KB2 | 0.60639856 |
| 75 | DAPK3 | 0.60582723 |
| 76 | MST1R | 0.59207782 |
| 77 | CSNK1G3 | 0.58379931 |
| 78 | STK10 | 0.56069576 |
| 79 | IRAK4 | 0.54864156 |
| 80 | BTK | 0.54288099 |
| 81 | PRPF4B | 0.52907532 |
| 82 | TRIB3 | 0.52551185 |
| 83 | SMG1 | 0.51395757 |
| 84 | MAPKAPK5 | 0.51194875 |
| 85 | LIMK1 | 0.50294408 |
| 86 | CHEK1 | 0.48965557 |
| 87 | GRK1 | 0.48721971 |
| 88 | EIF2AK1 | 0.47702362 |
| 89 | MAP3K9 | 0.47620158 |
| 90 | MAP3K11 | 0.44319954 |
| 91 | PINK1 | 0.44257164 |
| 92 | MATK | 0.44178990 |
| 93 | LYN | 0.43011918 |
| 94 | MAPKAPK2 | 0.42771967 |
| 95 | CDK12 | 0.42516689 |
| 96 | SYK | 0.42272562 |
| 97 | AKT2 | 0.40596719 |
| 98 | CSNK2A2 | 0.39447277 |
| 99 | PKN1 | 0.38613611 |
| 100 | MAP3K10 | 0.36175030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.70036731 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.62009043 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.24608217 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.90030421 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.70973652 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.47086346 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.46077941 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.27980993 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.26747336 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.23789764 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.09196066 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99445642 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 1.98484907 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.84988550 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66418589 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.60919678 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.59295439 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.58245312 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.56626928 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.54881453 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.54456411 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52287082 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48726245 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.46308385 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.43103235 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42191400 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39944267 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37704697 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36931721 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35584934 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.32474277 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.32136305 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.30162519 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.29986877 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23516168 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.21550842 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18206821 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17525420 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15608795 |
| 40 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15105238 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11405358 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 1.09806153 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09779755 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08328233 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08241264 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 1.06073363 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06072496 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03119593 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.99485437 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94463652 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92287991 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84247805 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83869866 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.83674098 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80187126 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78317973 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77989231 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 0.75888975 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74175808 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73843267 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73335437 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71212687 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71066993 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70547023 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69417913 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68577753 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68357039 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65340809 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65301786 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.63949876 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62625541 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61066133 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60442457 |
| 74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59682274 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58200124 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57788351 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57340456 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56608029 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.56014612 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.54873316 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.54831400 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53976389 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.53720098 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53542415 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50687242 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.49516429 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45559140 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41618957 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41232691 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.40889006 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.40489466 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.40224890 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.39954996 |
| 94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39403213 |
| 95 | Tuberculosis_Homo sapiens_hsa05152 | 0.38859632 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36290970 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35973910 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34629317 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.33769177 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33494217 |

